BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10819535)

  • 1. Functional characterization of BRCA1 and BRCA2: clues from their interacting proteins.
    Sharan SK; Bradley A
    J Mammary Gland Biol Neoplasia; 1998 Oct; 3(4):413-21. PubMed ID: 10819535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.
    Chen J; Silver DP; Walpita D; Cantor SB; Gazdar AF; Tomlinson G; Couch FJ; Weber BL; Ashley T; Livingston DM; Scully R
    Mol Cell; 1998 Sep; 2(3):317-28. PubMed ID: 9774970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible function found for breast cancer genes.
    Marx G
    Science; 1997 Apr; 276(5312):531-2. PubMed ID: 9148411
    [No Abstract]   [Full Text] [Related]  

  • 4. Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations.
    Ghimenti C; Sensi E; Presciuttini S; Brunetti IM; Conte P; Bevilacqua G; Caligo MA
    Genes Chromosomes Cancer; 2002 Mar; 33(3):235-42. PubMed ID: 11807980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway.
    Chen JJ; Silver D; Cantor S; Livingston DM; Scully R
    Cancer Res; 1999 Apr; 59(7 Suppl):1752s-1756s. PubMed ID: 10197592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair.
    Dong Y; Hakimi MA; Chen X; Kumaraswamy E; Cooch NS; Godwin AK; Shiekhattar R
    Mol Cell; 2003 Nov; 12(5):1087-99. PubMed ID: 14636569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.
    Rebbeck TR; Mitra N; Domchek SM; Wan F; Chuai S; Friebel TM; Panossian S; Spurdle A; Chenevix-Trench G; ; Singer CF; Pfeiler G; Neuhausen SL; Lynch HT; Garber JE; Weitzel JN; Isaacs C; Couch F; Narod SA; Rubinstein WS; Tomlinson GE; Ganz PA; Olopade OI; Tung N; Blum JL; Greenberg R; Nathanson KL; Daly MB
    Cancer Res; 2009 Jul; 69(14):5801-10. PubMed ID: 19584272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo.
    Yuan SS; Lee SY; Chen G; Song M; Tomlinson GE; Lee EY
    Cancer Res; 1999 Aug; 59(15):3547-51. PubMed ID: 10446958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homologous repair of DNA damage and tumorigenesis: the BRCA connection.
    Jasin M
    Oncogene; 2002 Dec; 21(58):8981-93. PubMed ID: 12483514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional domains of the BRCA1 and BRCA2 proteins.
    Baer R; Lee WH
    J Mammary Gland Biol Neoplasia; 1998 Oct; 3(4):403-12. PubMed ID: 10819534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAP1, a candidate tumor suppressor protein that interacts with BRCA1.
    Jensen DE; Rauscher FJ
    Ann N Y Acad Sci; 1999; 886():191-4. PubMed ID: 10667217
    [No Abstract]   [Full Text] [Related]  

  • 12. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
    Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
    Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New complexities for BRCA1 and BRCA2.
    Kerr P; Ashworth A
    Curr Biol; 2001 Aug; 11(16):R668-76. PubMed ID: 11525763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1-BARD1 promotes RAD51-mediated homologous DNA pairing.
    Zhao W; Steinfeld JB; Liang F; Chen X; Maranon DG; Jian Ma C; Kwon Y; Rao T; Wang W; Sheng C; Song X; Deng Y; Jimenez-Sainz J; Lu L; Jensen RB; Xiong Y; Kupfer GM; Wiese C; Greene EC; Sung P
    Nature; 2017 Oct; 550(7676):360-365. PubMed ID: 28976962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Brca1 and Brca2 proteins and tumor pathogenesis.
    Ingvarsson S
    Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein.
    Mizuta R; LaSalle JM; Cheng HL; Shinohara A; Ogawa H; Copeland N; Jenkins NA; Lalande M; Alt FW
    Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6927-32. PubMed ID: 9192668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer susceptibility and the functions of BRCA1 and BRCA2.
    Venkitaraman AR
    Cell; 2002 Jan; 108(2):171-82. PubMed ID: 11832208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer genes and DNA repair.
    Venkitaraman AR
    Science; 1999 Nov; 286(5442):1100-2. PubMed ID: 10610523
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumors.
    Honrado E; Osorio A; Palacios J; Milne RL; Sánchez L; Díez O; Cazorla A; Syrjakoski K; Huntsman D; Heikkilä P; Lerma E; Kallioniemi A; Rivas C; Foulkes WD; Nevanlinna H; Benítez J
    J Clin Oncol; 2005 Oct; 23(30):7503-11. PubMed ID: 16234517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.